PTX3, an important immunomodulatory molecule in glioma, has been reported to enhance macrophage infiltration and migration and to promote the malignant transformation of dendritic cells in the tumour microenvironment [41,57]. The gene discussed is PTX3; the disease is central nervous system cancer.